Drug hope for Crohn's patients: New treatment is first to work in the gut to target symptoms on the disease

Vedolizumab is the first to work directly in the gut lining, targeting the inflammation that causes chronic symptoms such as diarrhoea, bleeding and fatigue.



from Health | Mail Online http://ift.tt/1nFLTt2

via dailymail